FAIR Health data released this month showed more than 2% of adult patients now take a GLP-1 drug to treat overweight or obesity. Among all adult patients, the percentage who had an overweight or ...

Novo Nordisk has terminated its partnership with telehealth company Hims & Hers Health, accusing it of deceptively marketing weight-loss drugs.

The actress shares her weight loss journey, revealing she hopes to shed 40 pounds with Ozempic after struggling with body image and confidence.